Abstract | BACKGROUND: METHODS: RESULTS: A total of 85 patients were enrolled, 44 (BMS) and 41 (BMS+DEB). The median age was 67 (36-84) years and 68 (80%) were male. Fifty-two patients (61.2%) had NSTEMI and 33 patients (38.8%) UA. There was no difference in patient demographics, risk factors, and clinical characteristics, except for more smokers in the BMS+DEB group 18/41 (43.9%) vs 9/44 (20.5%). At follow-up, no significant difference in binary ISR was found; p=0.593, but LLL was significantly lower in the BMS+DEB group 0.68 (0.00-2.15) mm vs 0.22 (0.00-2.35) mm; p=0.002. The difference in major adverse cardiac events ( MACE) rate combining TLR, ST, and ACS, between the groups was also non-significant, 29.5% (BMS) vs 24.4% (BMS+DEB); p=0.835. One patient had a subacute ST (BMS+DEB) due to clopidogrel resistance. CONCLUSION: Patients treated with BMS+DEB combination for non-ST elevation acute coronary syndrome had significantly less LLL in comparison to patients treated with BMS alone but without an impact on patient clinical outcomes.
|
Authors | Kristina Maric Besic, Maja Strozzi, Eduard Margetic, Josko Bulum, Branko Kolaric |
Journal | Journal of cardiology
(J Cardiol)
Vol. 65
Issue 3
Pg. 203-7
(Mar 2015)
ISSN: 1876-4738 [Electronic] Netherlands |
PMID | 24976525
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. |
Topics |
- Acute Coronary Syndrome
(therapy)
- Adult
- Aged
- Aged, 80 and over
- Angina, Unstable
(therapy)
- Angioplasty, Balloon, Coronary
(methods)
- Drug-Eluting Stents
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(therapy)
- Risk Factors
- Stents
- Time Factors
- Treatment Outcome
|